Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Panvizyme 212.5mg Tablet

Prescription Icon
Prescription Required

Marketer

Binova Healthcare Pvt Ltd

Salt Composition

Pancreatin (212.5mg)

Overview Panvizyme 212.5mg Tablet

DigestAid 212.5mg tablets are prescribed for pancreatic enzyme insufficiency. This pancreatic enzyme supplement aids digestion, lessening bowel movements and easing stomach upset. Take DigestAid 212.5mg with or immediately after meals and snacks, accompanied by ample water, to optimize enzyme interaction with food. Dosage is individualized based on your health and response. Continue treatment as directed by your physician; long-term use is possible, so establish a consistent intake schedule. DigestAid 212.5mg may be part of a broader treatment plan including dietary modifications. Common side effects include abdominal pain, bloating, and loose stools. Report persistent or bothersome side effects to your doctor, as mitigation strategies may be available. Inform your physician about gout, asthma, allergies, or diabetes (as this medication might influence blood sugar management and your existing diabetes treatment). Avoid concurrent antacid use. Consult your doctor regarding use during pregnancy or breastfeeding. Regular blood tests may be conducted to monitor treatment efficacy.

Primary Ingredients of Panvizyme 212.5mg Tablet

The provided information is insufficient.

Uses of Panvizyme 212.5mg Tablet

Managing insufficient pancreatic enzymes

Major Benefits of Panvizyme 212.5mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Panvizyme 212.5mg Tablets should be administered with a meal.

Common Side effects of Panvizyme 212.5mg Tablet:

  • Stomach pain
  • Bloating
  • Diarrhea

How to use Panvizyme 212.5mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Panvizyme 212.5mg Tablet should be administered with a meal.

How Panvizyme 212.5mg Tablet works:

Pancreatic enzyme replacement therapy, pancreatin, aids digestion by readily combining with ingested food.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Panvizyme 212.5mg Tablet lacks established safety data. Physician consultation is advised.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Panvizyme 212.5mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Breastfeeding mothers can likely use Panvizyme 212.5mg tablets safely. Available human data indicates minimal infant risk associated with this medication.

DrivingDrivingSAFE

Driving ability is typically unaffected by Panvizyme 212.5mg tablets.

KidneyKidneyCONSULT YOUR DOCTOR

Data regarding Panvizyme 212.5mg Tablet use in individuals with renal impairment is scarce. Physician consultation is advised. Elevated uric acid is a potential concern in patients with pre-existing kidney conditions; therefore, careful monitoring is necessary.

LiverLiverCONSULT YOUR DOCTOR

Data regarding the use of Panvizyme 212.5mg tablets in individuals with hepatic impairment is scarce. Physician consultation is recommended.

What if you forget to take Panvizyme 212.5mg Tablet :

Should you forget a Panvizyme 212.5mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Panvizyme 212.5mg Tablet

LabelValue
Pharmaceutical Category Polypeptides
Potential for Dependence None.
Treatment Category Gastrointestinal tract
Mechanism of Action Agents that aid digestion

FAQs on Panvizyme 212.5mg Tablet

Pancreatic enzyme replacement therapy, such as Panvizyme 212.5mg tablets, combines various enzymes to aid digestion. This medication is prescribed for individuals with insufficient endogenous pancreatic enzyme production, including those post-pancreatectomy or experiencing pancreatic insufficiency.
Pancrelipase 212.5mg tablets are generally well-tolerated in patients using them to manage pancreatic insufficiency-related digestive problems. However, this medication may elevate blood uric acid, potentially exacerbating gout and leading to arthritic pain and swelling. Possible adverse effects include allergic responses such as skin eruptions, lip swelling, increased gas, abdominal discomfort, headache, and vertigo. Prior to initiating treatment, a comprehensive medical history, including allergies and current medications, should be discussed with your physician.
Consume the capsule with food, swallowing it whole. Follow with ample fluids. Increased fluid consumption is crucial while using Panvizyme 212.5mg Tablet. If swallowing capsules proves difficult, the granules may be extracted, combined with fruit juice or yogurt, and then ingested. Avoid crushing the granules.
Consuming five smaller meals can ease pancreatic digestion. A balanced, low-fat diet is crucial, minimizing saturated and trans fats. Focus on whole grains, fruits, vegetables, lean meats/poultry, beans, and low-fat dairy. Maintain adequate hydration with plenty of fluids. Discuss vitamin A, D, E, and K supplementation with your physician. Moderate intake of healthy polyunsaturated fats is acceptable. Smoking and alcohol must be avoided to protect your pancreas.
Panvizyme 212.5mg tablets are suitable for pediatric use. Children, as with adults, require adequate hydration during treatment. For infants under 12 months, the tablet contents may be administered directly into the mouth, followed by breast milk or formula. Avoid mixing the medication with the milk. Ensure complete ingestion to prevent oral irritation.
Panvizyme 212.5mg Tablet
29
MRP 35
17% off